Article: Tenormin included in 'standard care' results from GISSI-2 trial. (cardiac medication, Grupo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardio)

TENORMIN (R) INCLUDED IN 'STANDARD CARE' RESULTS FROM GISSI-2 TRIAL

FLORENCE, Italy, March 8 /PRNewswire/ -- ICI Pharma announced today a major multicenter study investigating acute myocardial infarction (AMI) patients has defined "standard care" in cardiac care unit (CCUs) worldwide. In this study, standard care included Tenormin (R) (atenolol), a cardioselective beta blocker which has demonstrated an essential role in the standard therapeutic regimen of AMI patients.

Investigators from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) announced that in GISSI-2, a 12,000 patient study designed to evaluate ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!